Godavari Drugs Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Godavari Drugs Ltd is ₹ 124.95 as of 05 May 15:30 . The p/e ratio of Godavari Drugs Ltd changed from 15 to 12.6 over 5 quarters. This represents a CAGR of -13.02% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Godavari Drugs Ltd changed from ₹ 65.86 crore to ₹ 70 crore over 5 quarters. This represents a CAGR of 5.00% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Godavari Drugs Ltd for the Jun '25 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 22.45 crore. This represent the decline of -100% The revenue of Procter & Gamble Health Ltd for the Jun '25 is ₹ 342.77 crore as compare to the Dec '25 revenue of ₹ 378.22 crore. This represent the decline of -9.37% The ebitda of Godavari Drugs Ltd for the Jun '25 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 2.75 crore. This represent the decline of -100% The ebitda of Procter & Gamble Health Ltd for the Jun '25 is ₹ 94.37 crore as compare to the Dec '25 ebitda of ₹ 114.82 crore. This represent the decline of -17.81% The net profit of Godavari Drugs Ltd changed from ₹ 0.77 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 66.18 crore over 7 quarters. This represents a CAGR of 22.25% The dividend payout of Godavari Drugs Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Godavari Drugs Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or Procter & Gamble Health Ltd?

Market cap of Godavari Drugs Ltd is 126 Cr while Market cap of Procter & Gamble Health Ltd is 8,566 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and Procter & Gamble Health Ltd?

The stock performance of Godavari Drugs Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and Procter & Gamble Health Ltd?

As of May 5, 2026, the Godavari Drugs Ltd stock price is INR ₹124.95. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5160.9.

How do dividend payouts of Godavari Drugs Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.